4547 — Kissei Pharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual income statement for Kissei Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	65,381	67,493	75,579	88,330	97,406
Cost of Revenue
Gross Profit	31,238	32,375	37,341	44,065	45,819
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	67,223	68,556	71,257	85,762	99,658
Operating Profit	-1,842	-1,063	4,322	2,568	-2,252
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	16,507	13,680	14,449	15,610	16,891
Provision for Income Taxes
Net Income After Taxes	13,032	10,634	11,290	11,976	13,961
Minority Interest
Net Income Before Extraordinary Items
Net Income	12,922	10,529	11,162	11,962	13,780
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	12,921	10,528	11,160	11,961	13,779
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	288	226	240	334	304
Dividends per Share
Special Dividends per Share